4.5 Article

A low-grade increase of serum pancreatic exocrine enzyme levels by dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes

Journal

DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 100, Issue 3, Pages E66-E69

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2013.03.034

Keywords

DPP-4 inhibitor; Type 2 diabetes mellitus; Pancreatic amylase; Lipase; Pancreatitis

Funding

  1. Grants-in-Aid for Scientific Research [23591297, 24591312] Funding Source: KAKEN

Ask authors/readers for more resources

A potential adverse effect of dipeptidyl peptidase-4 inhibitors (DPP-4i) on the pancreas remains controversial. We evaluated the DPP-4i effects on pancreatic amylase and lipase activity in patients with type 2 diabetes. These enzymes were slightly but significantly increased, suggesting DPP-4i cause a low-grade inflammatory change in the exocrine pancreas. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available